178 related articles for article (PubMed ID: 37335026)
1. Stimulated myotube contractions regulate membrane-bound and soluble TLR4 to prevent LPS-induced signaling and myotube atrophy in skeletal muscle cells.
Ducharme JB; Fennel ZJ; McKenna ZJ; Nava RC; Deyhle MR
Am J Physiol Cell Physiol; 2023 Jul; 325(1):C300-C313. PubMed ID: 37335026
[TBL] [Abstract][Full Text] [Related]
2. Divergent mechanisms regulate TLR4 expression on peripheral blood mononuclear cells following workload-matched exercise in normoxic and hypoxic environments.
Ducharme JB; McKenna ZJ; Specht JW; Fennel ZJ; Berkemeier QN; Deyhle MR
J Appl Physiol (1985); 2024 Jan; 136(1):33-42. PubMed ID: 37994415
[TBL] [Abstract][Full Text] [Related]
3. Flavones Inhibit LPS-Induced Atrogin-1/MAFbx Expression in Mouse C2C12 Skeletal Myotubes.
Shiota C; Abe T; Kawai N; Ohno A; Teshima-Kondo S; Mori H; Terao J; Tanaka E; Nikawa T
J Nutr Sci Vitaminol (Tokyo); 2015; 61(2):188-94. PubMed ID: 26052151
[TBL] [Abstract][Full Text] [Related]
4. Myeloma extracellular vesicle-derived RAGE increases inflammatory responses and myotube atrophy in multiple myeloma through activation of the TLR4/NF-κB p65 pathway.
Wu Y; Yao X; Shi X; Xu Z; Ren J; Shi M; Li M; Liu J; Du X
Apoptosis; 2024 Jun; 29(5-6):849-864. PubMed ID: 38117373
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways.
Doyle A; Zhang G; Abdel Fattah EA; Eissa NT; Li YP
FASEB J; 2011 Jan; 25(1):99-110. PubMed ID: 20826541
[TBL] [Abstract][Full Text] [Related]
6. Interaction of soluble form of recombinant extracellular TLR4 domain with MD-2 enables lipopolysaccharide binding and attenuates TLR4-mediated signaling.
Hyakushima N; Mitsuzawa H; Nishitani C; Sano H; Kuronuma K; Konishi M; Himi T; Miyake K; Kuroki Y
J Immunol; 2004 Dec; 173(11):6949-54. PubMed ID: 15557191
[TBL] [Abstract][Full Text] [Related]
7. TAK-242, a specific inhibitor of Toll-like receptor 4 signalling, prevents endotoxemia-induced skeletal muscle wasting in mice.
Ono Y; Maejima Y; Saito M; Sakamoto K; Horita S; Shimomura K; Inoue S; Kotani J
Sci Rep; 2020 Jan; 10(1):694. PubMed ID: 31959927
[TBL] [Abstract][Full Text] [Related]
8. Triptolide prevents LPS-induced skeletal muscle atrophy via inhibiting NF-κB/TNF-α and regulating protein synthesis/degradation pathway.
Fang WY; Tseng YT; Lee TY; Fu YC; Chang WH; Lo WW; Lin CL; Lo YC
Br J Pharmacol; 2021 Aug; 178(15):2998-3016. PubMed ID: 33788266
[TBL] [Abstract][Full Text] [Related]
9. Serum amyloid A1 mediates myotube atrophy via Toll-like receptors.
Hahn A; Kny M; Pablo-Tortola C; Todiras M; Willenbrock M; Schmidt S; Schmoeckel K; Jorde I; Nowak M; Jarosch E; Sommer T; Bröker BM; Felix SB; Scheidereit C; Weber-Carstens S; Butter C; Luft FC; Fielitz J
J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):103-119. PubMed ID: 31441598
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective effects of arjunolic acid in LPS-stimulated H9C2 and C2C12 myotubes via the My88-dependent TLR4 signaling pathway.
Hasan MM; Madhavan P; Ahmad Noruddin NA; Lau WK; Ahmed QU; Arya A; Zakaria ZA
Pharm Biol; 2023 Dec; 61(1):1135-1151. PubMed ID: 37497554
[TBL] [Abstract][Full Text] [Related]
11. Bacterial lipopolysaccharide induces rainbow trout myotube atrophy via Akt/FoxO1/Atrogin-1 signaling pathway.
Aedo JE; Reyes AE; Avendaño-Herrera R; Molina A; Valdés JA
Acta Biochim Biophys Sin (Shanghai); 2015 Nov; 47(11):932-7. PubMed ID: 26341977
[TBL] [Abstract][Full Text] [Related]
12. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
[TBL] [Abstract][Full Text] [Related]
13. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
14. Electrical stimulation prevents doxorubicin-induced atrophy and mitochondrial loss in cultured myotubes.
Guigni BA; Fix DK; Bivona JJ; Palmer BM; Carson JA; Toth MJ
Am J Physiol Cell Physiol; 2019 Dec; 317(6):C1213-C1228. PubMed ID: 31532714
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways.
Zhang G; Liu Z; Ding H; Miao H; Garcia JM; Li YP
Sci Rep; 2017 May; 7(1):2273. PubMed ID: 28536426
[TBL] [Abstract][Full Text] [Related]
16. Isoflavones derived from soy beans prevent MuRF1-mediated muscle atrophy in C2C12 myotubes through SIRT1 activation.
Hirasaka K; Maeda T; Ikeda C; Haruna M; Kohno S; Abe T; Ochi A; Mukai R; Oarada M; Eshima-Kondo S; Ohno A; Okumura Y; Terao J; Nikawa T
J Nutr Sci Vitaminol (Tokyo); 2013; 59(4):317-24. PubMed ID: 24064732
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1β triggers muscle-derived extracellular superoxide dismutase expression and protects muscles from doxorubicin-induced atrophy.
Yamada M; Okutsu M
J Physiol; 2023 Nov; 601(21):4699-4721. PubMed ID: 37815420
[TBL] [Abstract][Full Text] [Related]
18. sTLR4/MD-2 complex inhibits colorectal cancer in vitro and in vivo by targeting LPS.
Zou Y; Qin F; Chen J; Meng J; Wei L; Wu C; Zhang Q; Wei D; Chen X; Wu H; Chen X; Dai S
Oncotarget; 2016 Aug; 7(32):52032-52044. PubMed ID: 27409669
[TBL] [Abstract][Full Text] [Related]
19. Recombinant soluble forms of extracellular TLR4 domain and MD-2 inhibit lipopolysaccharide binding on cell surface and dampen lipopolysaccharide-induced pulmonary inflammation in mice.
Mitsuzawa H; Nishitani C; Hyakushima N; Shimizu T; Sano H; Matsushima N; Fukase K; Kuroki Y
J Immunol; 2006 Dec; 177(11):8133-9. PubMed ID: 17114488
[TBL] [Abstract][Full Text] [Related]
20. Palmitate-Induced Inflammation and Myotube Atrophy in C2C12 Cells Are Prevented by the Whey Bioactive Peptide, Glycomacropeptide.
de Hart NM; Petrocelli JJ; Nicholson RJ; Yee EM; Ferrara PJ; Bastian ED; Ward LS; Petersen BL; Summers SA; Drummond MJ
J Nutr; 2023 Oct; 153(10):2915-2928. PubMed ID: 37652286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
